Xiao‐Feng He
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Pharmacogenetics and Drug Metabolism 8
Xiao‐Feng He
91 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Hepatology 118
- Cancer Research 196
- Obstetrics and Gynecology 82
- Oncology 263
- Pathology and Forensic Medicine 148
Countries citing papers authored by Xiao‐Feng He
This map shows the geographic impact of Xiao‐Feng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Feng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Feng He more than expected).
Fields of papers citing papers by Xiao‐Feng He
This network shows the impact of papers produced by Xiao‐Feng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Feng He. The network helps show where Xiao‐Feng He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiao‐Feng He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 2 | |
| 12 | 2020 | 11 | |
| 13 | 2019 | 16 | |
| 14 | 2014 | 19 | |
| 15 | 2014 | 5 | |
| 16 | 2012 | 10 | |
| 17 | 2009 | 2 | |
| 18 | Intradiscal injection of O_2-O_3 to treat lumbar disc herniations: clinical therapeutic effect analysis with 600 cases | 2005 | 2 |
| 19 | Percutaneous lumbar discectomy | 2004 | 1 |
| 20 | A comparative study on necrosis and apoptosis of hepatocellular carcinoma cells after TACE with use of low-dose and conventional-dose anticancer drugs | 2003 | 3 |
About Xiao‐Feng He
Xiao‐Feng He is a scholar working on Pathology and Forensic Medicine, Pharmacology, Hepatology, Cancer Research and Oncology, having authored 97 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glutathione Transferases and Polymorphisms (17 papers), DNA Repair Mechanisms (14 papers), BRCA gene mutations in cancer (10 papers), Folate and B Vitamins Research (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), RNA modifications and cancer (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Hepatology (118 citations), Cancer Research (196 citations), Obstetrics and Gynecology (82 citations), Oncology (263 citations) and Pathology and Forensic Medicine (148 citations). Xiao‐Feng He has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Jiao Su, Dapeng Ding, Xianghua Ye, Xuliang Shen, Ying Zhang, Zhizhong Liu, Ying Zhang, Yuanhao Liang, Yanhao Li and Su-Lan Wang. Their work appears in journals such as PLoS ONE, Frontiers in Genetics, Medicine, Molecular Biology Reports and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.